Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT04481295Not ApplicableUnknown

Study on Optimal Oxygen Concentration During Pulmonary Rehabilitation

Role: lead

NCT05193136Recruiting

Sleep Hygiene, Sarcopenia, and Cognitive Function in Respiratory Disease

Role: lead

NCT05188976Unknown

Assessment of End-tidal Carbon Dioxide Levels in Respiratory Disease

Role: lead

NCT04471220Not ApplicableCompleted

Exercise Capacity Under Various FiO2 and Oxygen Flow Rates Using HFNC

Role: lead

NCT03550820Completed

Energy Metabolism for the Patients With Pulmonary Mycobacterium Avium Complex

Role: lead

NCT04590391Not ApplicableCompleted

Visual and Auditory Breathing-swallowing Coordinated Training

Role: lead

NCT02804243Not ApplicableCompleted

The Efficacy of Nasal High Flow Oxygen Therapy With Rehabilitation in the Patients With Chronic Respiratory Failure

Role: lead

All 7 trials loaded